Prevascar in African Continental Group Scarring

Status Active, not recruiting

Clinical Trial Summary

There is considerable variation in scarring, within and between people, and between different ethnic groups. Individuals with more pigmented skin are more prone to severe scarring than those traditionally termed white. Prevascar is being developed by Renovo for use as a potential treatment for reducing scarring.

Renovo's histological analysis of wounds and scars in human non drug studies demonstrates an increase in wound and scar width in subjects of African Caribbean ancestry over a 12 month period.

It is hypothesised that IL-10 may be a potentially beneficial therapy for the reduction of scarring in Non Caucasians of African-Caribbean ancestry.

This Renovo clinical trial will be carried out primarily to establish the effects of four doses of Prevascar on 1cm incisional and excisional scars in subjects of African Continental Group ancestry, as compared to placebo, and to further investigate the safety and tolerance of intradermally injected Prevascar in wounds.

Clinical Trial Description

n/a

Study Design

Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT01115868
Study type	Interventional
Source	Renovo
Contact
Status	Active, not recruiting
Phase	Phase 1
Start date	April 2010
Completion date	August 2012

View Details

See also
Status	Clinical Trial	Phase
Withdrawn	`NCT01995604` - Dehydrated Human Amnion/Chorion Membrane (dHACM) for Recovery After Fractionated Ablative CO2 Laser Resurfacing of the Face	N/A
Completed	`NCT05449457` - Aesthetic Outcome of Layered Closure vs. Layered Closure Followed by 2-Octyl Cyanoacrylate	N/A
Withdrawn	`NCT01704924` - Prospective Observation of Wound Healing With Prevena Incision Management System	N/A
Recruiting	`NCT05758168` - Aesthetic Outcome of Tie-over Bolster Application in Surgical Wounds	N/A
Completed	`NCT03424304` - Evaluation of Cutera Excel V™ Laser With Green Genesis and Micro-Lens Array (MLA)Attachment	N/A
Completed	`NCT02300909` - dHACM in Lumbar Decompression and Microdiscectomy Surgery	N/A
Active, not recruiting	`NCT04383912` - Onabotulinum Toxin A in Direct Brow Lift	N/A
Not yet recruiting	`NCT04593706` - Comparison of the Efficacy of Different Steroids in the Treatment of Abnormal Scars (Keloids, Hypertrophic Scars)	N/A
Enrolling by invitation	`NCT06448481` - Aesthetic Outcome of Intra-dermal Versus Transcutaneous Purse-string Closure	N/A
Not yet recruiting	`NCT05470322` - Efficacy and Tolerability of a Fractional Ablative Erbium Laser for Axillary Scarring for Hidradenitis Suppurativa Patients	N/A
Recruiting	`NCT06122090` - Treatment of Hypopigmented Scars With Bimatoprost	Phase 2
Completed	`NCT04331080` - A Study of Granexin® Gel for the Reduction of Scar Formation in Surgical Wounds Following Bilateral Anchor Incision Breast Surgery	Phase 2/Phase 3
Completed	`NCT03036306` - Dose Ranging Study to Evaluate the Safety and Tolerability of SCX-001 Cream in Healthy Volunteers With Induced Dermal Incisions	Phase 1
Completed	`NCT02630303` - High Fluence Light Emitting Diode-Red Light (LED-RL) in Human Skin	Phase 1
Completed	`NCT02088567` - Amniotic Membrane in Total Knee Replacements to Reduce Scarring	N/A
Completed	`NCT03514615` - A Trial to Assess the Safety and Efficacy of Topical Salbutamol in Healthy Volunteers.	Phase 1
Completed	`NCT02676115` - Medipore Tape Study	N/A
Completed	`NCT03424148` - Open-label, Prospective, Multicenter Study to Evaluate the Cutera Excel V™ Laser and a Micro-Lens Array Attachment	N/A
Not yet recruiting	`NCT04214236` - CiNPT for Abdominoplasties in Post-bariatric Patients Study	N/A
Completed	`NCT02247193` - Botulinum Toxin to Improve Cosmesis of Primary Cleft Lip Repair	Phase 1/Phase 2